Showing results (131-140 of 253) with videos related to
Sort By:
Pageof 26
Diabetes Research and Clinical Practice|July 21, 2026
Glucagon-like peptide-1 receptor agonists and new-onset atrial fibrillation in adults with diabetes or obesity: a multinational cohort studyChien-Hsiang Weng, Rohan Cherukuru, Chien-Chih Chou, et al.Health Services Research|December 31, 2025
Estimating Racial and Ethnic Disparities in Substance Use Disorder Treatment and Harm Reduction Services: Findings From a Survey of People Who Use DrugsJason B Gibbons, Sachini Bandara, Benjamin Le Cook, et al.Chest|January 18, 2005
Delays in suspicion and isolation among hospitalized persons with pulmonary tuberculosis at public and private US hospitals during 1996 to 1999Julia Rozovsky-Weinberger, Jorge P Parada, Laura Phan, et al.Cancer|March 29, 2006
Clinical features and correlates of gemcitabine-associated lung injury: findings from the RADAR projectSteven M Belknap, Timothy M Kuzel, Paul R Yarnold, et al.American Journal of Therapeutics|September 1, 2018
Investigating Serious Adverse Drug Reactions in Patients Receiving Erythropoiesis-Stimulating Agents: A Root Cause Analysis Using the "ANTICIPATE" FrameworkSony Jacob, Judy Nichols, Iain C Macdougall, et al.JAMA Network Open|August 12, 2024
Harm Reduction and Treatment Among People at High Risk of OverdoseSachini Bandara, Lauren Byrne, Vanessa Berman, et al.European Journal of Cancer Care|October 28, 2020
Do radiation oncologists and urologists endorse decision aids for active surveillance of low-risk prostate cancer: Results from a national surveyKang Puneet, Jon C Tilburt, Robert J Volk, et al.Clinical Prostate Cancer|July 5, 2005
Patient preferences in prostate cancer: a clinician's guide to understanding health utilitiesKaren M Kramer, Charles L Bennett, A Simon Pickard, et al.Transfusion|May 17, 2008
Epoetin-associated pure red cell aplasia: past, present, and future considerationsJune M McKoy, Robin E Stonecash, Denis Cournoyer, et al.BMJ Health & Care Informatics|May 13, 2021
Comparison and impact of COVID-19 for patients with cancer: a survival analysis of fatality rate controlling for age, sex and cancer typeHaiquan Li, Edwin Baldwin, Xiang Zhang, et al.Pageof 26